Genetic polymorphisms of INSIG2 were associated with coronary artery disease in Uygur Chinese population in Xinjiang, China
暂无分享,去创建一个
Li | Ma | Yun | Chen | Fu | Huang | Xie | Fen | Gai | Zheng | Xiao-mei | Yang | Liu | Wu | Ding | Xiang | Bang-Dang | Zhen-yan | Ying-ying | Min-tao | Baituola | Xiao-cui | Dilare | Yi-ning | Gulinaer
[1] S. Rampal,et al. Genetic associations of the INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays. , 2014, Genetics and molecular research : GMR.
[2] Xiang Ma,et al. Polymorphisms in the SAA1 gene are associated with ankle-to-brachial index in Han Chinese healthy subjects , 2011, Blood pressure.
[3] Jin Ye,et al. Regulation of cholesterol and fatty acid synthesis. , 2011, Cold Spring Harbor perspectives in biology.
[4] J. Kastelein,et al. Lipid parameters for measuring risk of cardiovascular disease , 2011, Nature Reviews Cardiology.
[5] Xiang Ma,et al. Polymorphisms in the SAA1/2 Gene Are Associated with Carotid Intima Media Thickness in Healthy Han Chinese Subjects: The Cardiovascular Risk Survey , 2010, PloS one.
[6] F. Clavel-Chapelon,et al. The INSIG2 rs7566605 polymorphism is not associated with body mass index and breast cancer risk , 2010, BMC Cancer.
[7] Swneke D. Bailey,et al. Fine Mapping of the Insulin-Induced Gene 2 Identifies a Variant Associated With LDL Cholesterol and Total Apolipoprotein B Levels , 2010, Circulation. Cardiovascular genetics.
[8] S. Kelsey,et al. Association of an INSIG2 obesity allele with cardiovascular phenotypes is gender and age dependent , 2010, BMC cardiovascular disorders.
[9] M. Fornage,et al. Common INSIG2 polymorphisms are associated with age-related changes in body size and high-density lipoprotein cholesterol from young adulthood to middle age. , 2010, Metabolism: clinical and experimental.
[10] Y. Jo,et al. Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase , 2010, Critical reviews in biochemistry and molecular biology.
[11] H. Shin,et al. Association analyses of the INSIG2 polymorphism in the obesity and cholesterol levels of Korean populations , 2009, BMC Medical Genetics.
[12] J. Norris,et al. INSIG2 SNPs Associated With Obesity and Glucose Homeostasis Traits in Hispanics: The IRAS Family Study , 2009, Obesity.
[13] S. Wiedmann,et al. Lack of Association Between a Common Polymorphism Near the INSIG2 Gene and BMI, Myocardial Infarction, and Cardiovascular Risk Factors , 2009, Obesity.
[14] Bang-dang Chen,et al. Haplotype Analysis of the CYP8A1 Gene Associated With Myocardial Infarction , 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[15] Jun Ma,et al. Association of the common genetic variant upstream of INSIG2 gene with obesity related phenotypes in Chinese children and adolescents. , 2008, Biomedical and environmental sciences : BES.
[16] Jianfeng Huang,et al. The INSIG1 gene, not the INSIG2 gene, associated with coronary heart disease: tagSNPs and haplotype-based association study , 2008, Thrombosis and Haemostasis.
[17] T. Hansen,et al. Non-Replication of Genome-Wide Based Associations between Common Variants in INSIG2 and PFKP and Obesity in Studies of 18,014 Danes , 2008, PloS one.
[18] N. Kohno,et al. The single nucleotide polymorphism upstream of insulin-induced gene 2 ( INSIG2) is associated with the prevalence of hypercholesterolaemia, but not with obesity, in Japanese American women. , 2008, The British journal of nutrition.
[19] A. Hamsten,et al. Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation. , 2008, The Journal of clinical endocrinology and metabolism.
[20] Joseph L. Goldstein,et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig , 2007, Proceedings of the National Academy of Sciences.
[21] Alan D. Lopez,et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.
[22] F. Hu,et al. A Common Genetic Variant Is Associated with Adult and Childhood Obesity , 2006, Science.
[23] M. Abney,et al. The sex-specific genetic architecture of quantitative traits in humans , 2006, Nature Genetics.
[24] R. Hammer,et al. Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. , 2005, The Journal of clinical investigation.
[25] Q. Kong,et al. Different matrilineal contributions to genetic structure of ethnic groups in the silk road region in china. , 2004, Molecular biology and evolution.
[26] Jinping Li,et al. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] Joseph L Goldstein,et al. Insig-dependent Ubiquitination and Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-CoA Reductase Stimulated by Sterols and Geranylgeraniol* , 2003, Journal of Biological Chemistry.
[28] J. Goldstein,et al. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Aebersold,et al. Crucial Step in Cholesterol Homeostasis Sterols Promote Binding of SCAP to INSIG-1, a Membrane Protein that Facilitates Retention of SREBPs in ER , 2002, Cell.
[30] Jinping Li,et al. Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. , 2002, American journal of physiology. Endocrinology and metabolism.
[31] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[32] J. Goldstein,et al. Overexpression of Membrane Domain of SCAP Prevents Sterols from Inhibiting SCAP·SREBP Exit from Endoplasmic Reticulum* , 2000, The Journal of Biological Chemistry.
[33] N. Spinner,et al. Cloning, human chromosomal assignment, and adipose and hepatic expression of the CL-6/INSIG1 gene. , 1997, Genomics.
[34] J. Goldstein,et al. The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.
[35] X. Hua,et al. Sterol Resistance in CHO Cells Traced to Point Mutation in SREBP Cleavage–Activating Protein , 1996, Cell.
[36] H. Narita,et al. The membrane domain of 3-hydroxy-3-methylglutaryl-coenzyme A reductase confers endoplasmic reticulum localization and sterol-regulated degradation onto beta-galactosidase. , 1988, The Journal of biological chemistry.
[37] J. Goldstein,et al. Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme , 1985, Cell.
[38] D. Weeks,et al. INSIG2 variants, dietary patterns and metabolic risk in Samoa , 2013, European Journal of Clinical Nutrition.
[39] T. Meitinger,et al. INSIG2 promoter variant, obesity markers and lipid parameters - No association in a large Slavonic Caucasian population sample. , 2010, Folia biologica.
[40] G. Moneta,et al. Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .
[41] [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. , 2007, Zhonghua xin xue guan bing za zhi.
[42] J. Goldstein,et al. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. , 2003, Molecular cell.